4//SEC Filing
Dicerna Pharmaceuticals Inc 4
Accession 0000904454-17-000306
CIK 0001399529operating
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 6:04 PM ET
Size
13.0 KB
Accession
0000904454-17-000306
Insider Transaction Report
Form 4
DP VIII Associates, L.P.
10% Owner
Transactions
- Purchase
Redeemable Convertible Preferred Stock
2017-04-11$100.00/sh+368$36,800→ 368 totalExercise: $3.19→ Common Stock (11,536 underlying)
DOVEY BRIAN H
10% Owner
Transactions
- Purchase
Redeemable Convertible Preferred Stock
2017-04-11$100.00/sh+368$36,800→ 368 totalExercise: $3.19→ Common Stock (11,536 underlying)
VITULLO NICOLE
10% Owner
Transactions
- Purchase
Redeemable Convertible Preferred Stock
2017-04-11$100.00/sh+368$36,800→ 368 totalExercise: $3.19→ Common Stock (11,536 underlying)
Halak Brian K
Director10% Owner
Transactions
- Purchase
Redeemable Convertible Preferred Stock
2017-04-11$100.00/sh+368$36,800→ 368 totalExercise: $3.19→ Common Stock (11,536 underlying)
BLAIR JAMES C
10% Owner
Transactions
- Purchase
Redeemable Convertible Preferred Stock
2017-04-11$100.00/sh+368$36,800→ 368 totalExercise: $3.19→ Common Stock (11,536 underlying)
TREU JESSE I
10% Owner
Transactions
- Purchase
Redeemable Convertible Preferred Stock
2017-04-11$100.00/sh+368$36,800→ 368 totalExercise: $3.19→ Common Stock (11,536 underlying)
Footnotes (3)
- [F1]The Redeemable Convertible Preferred Stock is immediately convertible, provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date.
- [F2]The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F3]As managing members of the sole general partner of Domain Partners VIII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VIII, L.P., as reported on a Form 4 for Domain Partners VIII, L.P. filed on the same date as this Form 4.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001399529
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 6:04 PM ET
- Size
- 13.0 KB